Nuveen California Select Tax-Free Income Portfolio NXC
Set alert
13.29 USD 0.00 0.00%
At close · Jan 9
13.34 +0.05 +0.38%
After hours · Jan 9, 4:00 PM ET
13.24 Day range 13.30
12.75 52-week range 14.18
- YTD
- +0.68%
- 1 year
- +2.39%
- Open
- 13.27
- Prev close
- 13.29
- Mkt cap
- 83.60M
- Vol
- 76.96K
- Avg vol
- 19.52K
- EPS
- 0.85
- P/E
- 15.46
- Div yield
- 4.21%
More statistics
- Low
- 13.24
- High
- 13.30
- Forward P/E
- 0.00
- Beta
- 0.28
- Short ratio
- 0.81
- Inst. own
- 16.67%
- Dividend
- 0.55
- Ex-div date
- Jun 13, 2024
- 50-d avg
- 13.51
- 200-d avg
- 13.43
- 1y target
- 0.00
2Y chart
Events in this range
- Feb 14, 2024Dividend: 0.0455
- Mar 14, 2024Dividend: 0.0455
- Apr 12, 2024Dividend: 0.0455
- May 14, 2024Dividend: 0.0455
- Jun 14, 2024Dividend: 0.0455
- Jul 15, 2024Dividend: 0.0455
- Aug 15, 2024Dividend: 0.0455
- Sep 13, 2024Dividend: 0.0455
- Oct 15, 2024Dividend: 0.0455
- Nov 15, 2024Dividend: 0.0455
- Dec 13, 2024Dividend: 0.0455
- Jan 15, 2025Dividend: 0.0455
- Feb 14, 2025Dividend: 0.0455
- Mar 14, 2025Dividend: 0.0455
- Apr 15, 2025Dividend: 0.0455
- May 15, 2025Dividend: 0.0455
- Jun 13, 2025Dividend: 0.0455
- Jul 15, 2025Dividend: 0.0455
- Aug 15, 2025Dividend: 0.0455
- Sep 15, 2025Dividend: 0.043
- Oct 15, 2025Dividend: 0.043
- Nov 14, 2025Dividend: 0.043
- Dec 15, 2025Dividend: 0.043
Signals (110)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Jan 7, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 7, 2026 | 9 months ago |
| SMA: Bearish | Jan 2, 2026 | 10 months ago |
| MACD: Sell Signal | Jan 2, 2026 | 10 months ago |
| SMA: Bullish | Dec 31, 2025 | 10 months ago |
| SMA: Bearish | Dec 29, 2025 | 10 months ago |
| SMA: Bullish | Dec 24, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 24, 2025 | 10 months ago |
| SMA: Bearish | Dec 23, 2025 | 10 months ago |
| SMA: Bearish | Dec 12, 2025 | 10 months ago |
| MACD: Sell Signal | Nov 17, 2025 | 11 months ago |
| RSI: Overbought | Nov 4, 2025 | 12 months ago |
| MACD: Buy Signal | Oct 30, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 17, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 6, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 3, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 1, 2025 | 1 year ago |
| SMA: Bullish | Sep 29, 2025 | 1 year ago |
| SMA: Bearish | Sep 25, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 25, 2025 | 1 year ago |
| SMA: Bullish | Sep 23, 2025 | 1 year ago |
| SMA: Bearish | Sep 17, 2025 | 1 year ago |
| SMA: Bullish | Sep 16, 2025 | 1 year ago |
| SMA: Bearish | Sep 12, 2025 | 1 year ago |
| SMA: Bullish | Sep 5, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 29, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 18, 2025 | 1 year ago |
| SMA: Bearish | Aug 15, 2025 | 1 year ago |
| SMA: Bullish | Aug 13, 2025 | 1 year ago |
| SMA: Bearish | Aug 12, 2025 | 1 year ago |
| SMA: Bullish | Aug 11, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 7, 2025 | 1 year ago |
| SMA: Bearish | Aug 6, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 6, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 4, 2025 | 1 year ago |
| SMA: Bullish | Aug 1, 2025 | 1 year ago |
| SMA: Bearish | Jul 22, 2025 | 1 year ago |
| SMA: Bullish | Jul 17, 2025 | 1 year ago |
| SMA: Bearish | Jul 16, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 15, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 14, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 10, 2025 | 1 year ago |
| SMA: Bullish | Jun 25, 2025 | 1 year ago |
| SMA: Bullish | Jun 18, 2025 | 1 year ago |
| SMA: Bearish | Jun 17, 2025 | 1 year ago |
| SMA: Bullish | Jun 6, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 6, 2025 | 1 year ago |
| MACD: Sell Signal | May 20, 2025 | 1 year ago |
| SMA: Bearish | May 19, 2025 | 1 year ago |
| SMA: Bullish | May 16, 2025 | 1 year ago |
| SMA: Bearish | May 15, 2025 | 1 year ago |
| SMA: Bullish | May 6, 2025 | 1 year ago |
| SMA: Bearish | May 2, 2025 | 1 year ago |
| SMA: Bullish | May 1, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 28, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 7, 2025 | 1 year ago |
| SMA: Bearish | Apr 4, 2025 | 1 year ago |
| SMA: Bearish | Mar 27, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 24, 2025 | 1 year ago |
| SMA: Bullish | Mar 21, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 13, 2025 | 1 year ago |
| SMA: Bullish | Mar 11, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 11, 2025 | 1 year ago |
| SMA: Bearish | Mar 4, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 4, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 28, 2025 | 1 year ago |
| SMA: Bullish | Feb 26, 2025 | 1 year ago |
| SMA: Bearish | Feb 24, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 13, 2025 | 1 year ago |
| SMA: Bearish | Feb 12, 2025 | 1 year ago |
| SMA: Bullish | Feb 11, 2025 | 1 year ago |
| SMA: Bearish | Feb 10, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 3, 2025 | 1 year ago |
| MACD: Sell Signal | Dec 30, 2024 | 1 year ago |
| MACD: Buy Signal | Dec 26, 2024 | 1 year ago |
| MACD: Sell Signal | Dec 9, 2024 | 1 year ago |
| SMA: Bearish | Dec 5, 2024 | 1 year ago |
| SMA: Bullish | Nov 27, 2024 | 1 year ago |
| MACD: Buy Signal | Nov 26, 2024 | 1 year ago |
| SMA: Bearish | Nov 18, 2024 | 1 year ago |
| SMA: Bullish | Nov 13, 2024 | 1 year ago |
| SMA: Bearish | Nov 12, 2024 | 1 year ago |
| MACD: Sell Signal | Nov 12, 2024 | 1 year ago |
| MACD: Buy Signal | Nov 7, 2024 | 1 year ago |
| SMA: Bearish | Oct 21, 2024 | 2 years ago |
| MACD: Sell Signal | Oct 3, 2024 | 2 years ago |
| MACD: Buy Signal | Sep 19, 2024 | 2 years ago |
| MACD: Sell Signal | Sep 16, 2024 | 2 years ago |
| MACD: Buy Signal | Sep 10, 2024 | 2 years ago |
| MACD: Sell Signal | Aug 16, 2024 | 2 years ago |
| RSI: Overbought | Aug 1, 2024 | 2 years ago |
| SMA: Bullish | Jul 10, 2024 | 2 years ago |
| MACD: Buy Signal | Jul 3, 2024 | 2 years ago |
| MACD: Sell Signal | Jun 21, 2024 | 2 years ago |
| SMA: Bearish | Jun 20, 2024 | 2 years ago |
| SMA: Bullish | Jun 18, 2024 | 2 years ago |
| SMA: Bearish | Jun 17, 2024 | 2 years ago |
| SMA: Bullish | Jun 13, 2024 | 2 years ago |
| SMA: Bearish | Jun 12, 2024 | 2 years ago |
| SMA: Bullish | Jun 10, 2024 | 2 years ago |
| MACD: Buy Signal | Jun 10, 2024 | 2 years ago |
| MACD: Sell Signal | May 22, 2024 | 2 years ago |
| SMA: Bearish | May 21, 2024 | 2 years ago |
| RSI: Overbought | May 15, 2024 | 2 years ago |
| SMA: Bullish | May 2, 2024 | 2 years ago |
| MACD: Buy Signal | Apr 29, 2024 | 2 years ago |
| RSI: Oversold | Apr 15, 2024 | 2 years ago |
| SMA: Bearish | Apr 5, 2024 | 2 years ago |
| MACD: Sell Signal | Apr 3, 2024 | 2 years ago |
| MACD: Buy Signal | Mar 14, 2024 | 2 years ago |
Key statistics
- Market cap
- 83.60M
- Enterprise value
- 82.34M
- Trailing P/E
- 15.46
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 22.62
- Price / book
- 0.94
- EPS (TTM)
- 0.85
- Beta
- 0.28
- Dividend yield
- 4.21%
- Payout ratio
- 66.25%
- Profit margin
- 137.94%
- Revenue (TTM)
- 3.70M
- Revenue growth
- 1.60%
- Free cash flow
- 0
- Total cash
- 118.75K
- Total debt
- 0
- Return on equity
- 5.79%
- Shares outstanding
- 6.36M
- Short % of float
- 0.28%
- 50-day average
- 13.51
- 200-day average
- 13.43
Analyst view
Consensus: none
Price target (mean) 0.00
Next earnings
Consensus EPS estimate 0.00.
About Nuveen California Select Tax-Free Income Portfolio
Nuveen California Select Tax-Free Income Portfolio is a closed-ended fixed income mutual fund launched by Nuveen Investments Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. It invests in the fixed income markets of California. The fund invests in the securities of companies that operate across diversified sectors. It primarily invests in municipal bonds. The fund employs fundamental analysis to create its portfolio. It benchmarks the performance of its portfolio against Barclays Capital California Municipal Bond Index and S&P California Municipal Bond Index. Nuveen California Select Tax-Free Income Portfolio was formed on June 19, 1992 and is domiciled in the United States.
- Sector
- Financial Services
- Industry
- Asset Management
- Country
- United States
News
- Immix Biopharma Reports 89% Complete Response in NXC-201 AL Amyloidosis Study
- Immix Biopharma Receives U.S. FDA Breakthrough Therapy Designation for NXC-201
- Nuveen Select Tax-Free Income Portfolios Announce Completion of Reorganizations
- Nuveen Closed-End Funds Announce Update to Reorganization Distributions
- Nuveen Select Tax-Free Income Portfolios Announce Shareholder Approval of Reorganization
- Immix Biopharma Appoints Chief Commercial Officer to Drive NXC-201 Launch
- Immix Biopharma's NXC-201 NEXICART-2 Clinical Trial Results Selected for Oral Presentation at ASH 2025
- Nuveen Wants To Merge NXC And NXN Into NXP: What Now?
- Immix Biopharma Announces Primary Endpoint Met in positive NXC-201 Interim Results Presented at ASCO, Enabling Path to Best-in-Class Therapy for relapsed/refractory AL Amyloidosis
- Immix Biopharma Announces Positive Results for NXC-201 at ASCO Oral Presentation, Enabling Pathway to Best-in-Class Therapy for relapsed/refractory AL Amyloidosis
Your note
Sign in to keep a note on NXC — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| LPL Financial LLC | 2.36% | 149,941 | 1.97M | Sep 29, 2024 |
| Guggenheim Capital, LLC | 2.16% | 137,580 | 1.81M | Sep 29, 2024 |
| Ameriprise Financial, Inc. | 0.90% | 57,086 | 750.11K | Sep 29, 2024 |
| Bank of America Corporation | 0.89% | 56,350 | 740.44K | Sep 29, 2024 |
| Morgan Stanley | 0.81% | 51,690 | 679.21K | Sep 29, 2024 |
| Hennion & Walsh Asset Management, Inc. | 0.75% | 47,704 | 626.83K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Rydex Variable Trust-Multi Hedge Strategies Fund | 0.01% | 412 | 5.41K | Jun 29, 2024 |